ARS Pharmaceuticals, Inc. SPRY Preferred Stock
Preferred Stock at other companies
Other financials
Where this comes from
Reported directly by ARS Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockValue.
The official record: ARS Pharmaceuticals, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about ARS Pharmaceuticals, Inc.'s preferred stock.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ARS Pharmaceuticals, Inc.'s preferred stock?
- ARS Pharmaceuticals, Inc. (SPRY) reported preferred stock of $0 in Q1 2026.
- What does preferred stock mean?
- Equity securities with priority over common stock for dividends and liquidation proceeds, but typically without voting rights.